Nxera Launches Broad Proprietary Pipeline Targeting Obesity And Chronic Weight Management
06/08/2025 24:31
Aug 6 (Reuters) - Nxera Pharma Co Ltd 4565.T: NXERA PHARMA CO LTD: NXERA LAUNCHES BROAD PROPRIETARY PIPELINE TARGETING OBESITY AND CHRONIC WEIGHT MANAGEMENT Source text: ID:nTSte81b42 Further company coverage: 4565.T (Reporting by Tokyo Newsroom) ((+81345201189;))
Recent news on Nxera Pharma
See all newsNxera Pharma Submits Marketing Authorization Application For Vamorolone In South Korea For Treatment Of Duchenne Muscular Dystrophy
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Nxera Pharma - Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-Pacific Markets
Brief: Nxera Announces Successful Resolution Of Minig Patent Infringement Action
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up